click below
click below
Normal Size Small Size show me how
WEEK 22:
Lung cancer treatment and prognosis:
| Question | Answer |
|---|---|
| predictors of survival (3) | tumour related factors (eg stage of disease, tumour size and location), patient related factors (etc age, smoking), and treatment related factors (eg treatment adherence or access to care) |
| types of treatment (2) | curative and palliative |
| curative treatment (3) | surgery, radical radiotherapy (including stereotactic ablative radiotherapy SABR), and radical chemotherapy |
| classification of LC (3) | SCLC, NSCLC (lung adenocarcinoma, squamous cell carcinoma, and large cell carcinoma), and pulmonary carcinoid tumours |
| palliative treatment (3) | radiotherapy, systemic anticancer treatment, and combinations |
| modalities of treatment (4) | radiotherapy, chemotherapy, chemo-radio, and surgery |
| adenocarcinoma | mutations in EGFR |
| squamous cell carcinoma | associated withTP53 |
| induction chemotherapy | |
| neo-adjuvant chemotherapy | |
| adjuvant chemotherapy | post op to reduce chance of metastasis |
| adjuvant immunotherapy | |
| targeted treatment | drugs designed to attack specific genetic mutations (driver mutations) to kill cancer cells and spare healthy cells |
| how is cancer treatment chosen | based on cancer type (NSCLC etc), stage, molecular profile (etc EGFR), and patient factor (etc age, comorbidities and preferences) |
| NSCLC treatment** | high prevalence of targetable mutations where stage storngly determines surgery etc |
| SCLC treatment | |
| carcinoid tumours treatment | |
| monoclonal antibodies | |
| treatment for no driver mutation cancer tumours** | immunotherapy +/- chemotherapy when PDL1.. |
| immune checkpoint inhibitors | |
| role of PD1** | bind to PDL1 on the lung cancer cell become 'exhausted' and inhibits growth |
| SABR (stereotactic ablative body radiotherapy) or stereotactic body radiotherapy SBT | |
| No fly zone - complications | massive haemoptysis, penumonia, airway necrosis, and pericardial effusion |
| RATS (robotic assisted thoracic surgery) | |
| follow up care | crucial in monitoring patients recovering and detecting recurrence, managing side effects of treatment and improving long term outcomes |